Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019047811) USE OF DOCETAXEL CONJUGATE IN PREPARATION OF DRUG FOR PREVENTING OR TREATING VARIOUS IMMUNE DISEASES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/047811 International Application No.: PCT/CN2018/103886
Publication Date: 14.03.2019 International Filing Date: 04.09.2018
IPC:
C07K 5/037 (2006.01) ,A61K 47/64 (2017.01) ,A61K 31/337 (2006.01) ,A61P 37/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
5
Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
02
containing at least one abnormal peptide link
037
the abnormal link being formed by the side chain of an alpha-amino acid, e.g. gamma-Glu, epsilon-Lys, glutathione
[IPC code unknown for A61K 47/64]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
337
having four-membered rings, e.g. taxol
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
Applicants:
深圳信立泰药业股份有限公司 SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD [CN/CN]; 中国广东省深圳市 福田区深南大道6009号车公庙绿景广场主楼37层 37F, Main Tower, Lvjing plaza, Che Gong Miao No. 6009 Shennan Road, Futian District Shenzhen, Guangdong 518040, CN
Inventors:
刘刚 LIU, Gang; CN
温晓明 WEN, Xiaoming; CN
欧颖烨 OU, Yingye; CN
黄伟鑫 HUANG, Weixin; CN
Priority Data:
201710798304.007.09.2017CN
Title (EN) USE OF DOCETAXEL CONJUGATE IN PREPARATION OF DRUG FOR PREVENTING OR TREATING VARIOUS IMMUNE DISEASES
(FR) UTILISATION D'UN CONJUGUÉ DU DOCÉTAXEL DANS LA PRÉPARATION D'UN MÉDICAMENT POUR LA PRÉVENTION OU LE TRAITEMENT DE DIVERSES MALADIES IMMUNITAIRES
(ZH) 多西紫杉醇共缀物在制备预防或治疗各种免疫疾病的药物中的应用
Abstract:
(EN) Disclosed is the use of a compound of formula (I) as shown below or a pharmaceutically acceptable salt thereof in the preparation of a drug for preventing or treating various immune diseases.
(FR) L'invention concerne l'utilisation d'un composé de formule (I) tel que représenté ci-dessous ou un sel pharmaceutiquement acceptable de celui-ci dans la préparation d'un médicament pour la prévention ou le traitement de diverses maladies immunitaires.
(ZH) 如下所示的式(I)的化合物或其药学上可接受的盐在制备预防或治疗各种免疫疾病的药物中的用途。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)